Depression

MD IQ

Pearls

Intranasal esketamine: A primer

Intranasal esketamine is an FDA-approved ketamine molecule indicated for use together with an oral antidepressant for treatment-resistant...

From the Journals

Melatonin: A new way to reduce self-harm?

Melatonin may reduce the risk of self-harm by treating sleep problems related to psychiatric comorbidities, especially anxiety and depression.

Pages